Search research articles
Contact Us
Filters
Showing results (681-690 of 818) with videos related to
Page
of 82
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry
|
March 21, 2015
Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study
Melgious J Y Ang, Qiu Ying Lau, Fui Mee Ng, et al.
The Journal of Biological Chemistry
|
July 2, 2016
Escherichia coli Topoisomerase IV E Subunit and an Inhibitor Binding Mode Revealed by NMR Spectroscopy
Yan Li, Ying Lei Wong, Fui Mee Ng, et al.
Analytical Biochemistry
|
August 18, 2009
A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease
Christophe Bodenreider, David Beer, Thomas H Keller, et al.
Physical Therapy
|
September 5, 2023
Finding the Optimal Resistance Training Intensity for Your Bones: Protocol for a Randomized Controlled Trial
Lora M Giangregorio, Robert R Bleakney, Sheila Brien, et al.
Eclinicalmedicine
|
September 10, 2024
Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension
Smeeta Sinha, Sagar U Nigwekar, Vincent Brandenburg, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 26, 2005
Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors
Zheng Yin, Sejal J Patel, Wei-Ling Wang, et al.
Journal of Medicinal Chemistry
|
July 16, 2011
Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824)
Joseph Cherian, Inhee Choi, Amit Nayyar, et al.
International Journal of Obesity (2005)
|
August 18, 2022
Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight
Maria S Svane, Helle H Johannesen, Adam E Hansen, et al.
Diabetes, Obesity & Metabolism
|
June 5, 2020
No effects of a 6-week intervention with a glucagon-like peptide-1 receptor agonist on pancreatic volume and oedema in obese men without diabetes
Maria S Svane, Helle H Johannesen, Christoffer Martinussen, et al.
Angewandte Chemie (International Ed. in English)
|
May 19, 2021
Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*
David Quach, Guanghui Tang, Jothi Anantharajan, et al.
Page
of 82
Search research articles
Search
Showing results (681-690 of 818) with videos related to
Sort By:
Page
of 82
Journal of Enzyme Inhibition and Medicinal Chemistry
|
March 21, 2015
Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study
Melgious J Y Ang, Qiu Ying Lau, Fui Mee Ng, et al.
The Journal of Biological Chemistry
|
July 2, 2016
Escherichia coli Topoisomerase IV E Subunit and an Inhibitor Binding Mode Revealed by NMR Spectroscopy
Yan Li, Ying Lei Wong, Fui Mee Ng, et al.
Analytical Biochemistry
|
August 18, 2009
A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease
Christophe Bodenreider, David Beer, Thomas H Keller, et al.
Physical Therapy
|
September 5, 2023
Finding the Optimal Resistance Training Intensity for Your Bones: Protocol for a Randomized Controlled Trial
Lora M Giangregorio, Robert R Bleakney, Sheila Brien, et al.
Eclinicalmedicine
|
September 10, 2024
Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension
Smeeta Sinha, Sagar U Nigwekar, Vincent Brandenburg, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 26, 2005
Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors
Zheng Yin, Sejal J Patel, Wei-Ling Wang, et al.
Journal of Medicinal Chemistry
|
July 16, 2011
Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824)
Joseph Cherian, Inhee Choi, Amit Nayyar, et al.
International Journal of Obesity (2005)
|
August 18, 2022
Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight
Maria S Svane, Helle H Johannesen, Adam E Hansen, et al.
Diabetes, Obesity & Metabolism
|
June 5, 2020
No effects of a 6-week intervention with a glucagon-like peptide-1 receptor agonist on pancreatic volume and oedema in obese men without diabetes
Maria S Svane, Helle H Johannesen, Christoffer Martinussen, et al.
Angewandte Chemie (International Ed. in English)
|
May 19, 2021
Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*
David Quach, Guanghui Tang, Jothi Anantharajan, et al.
Page
of 82